Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (401-410 of 1,398) with videos related to

Pageof 140
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)G S Hagopian, G B Mills, A R Khokhar, et al.
British Journal of Cancer|November 30, 2019
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancersMusaffe Tuna, Zhenlin Ju, Kosuke Yoshihara, et al.
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data SetsWei Zhao, Matthew Fitzgibbon, Lindsay Bergan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Dissociation of cytokine signals for proliferation and apoptosisY Shi, R Wang, A Sharma, et al.
Nature Communications|April 15, 2020
Sex-associated molecular differences for cancer immunotherapyYouqiong Ye, Ying Jing, Liang Li, et al.
Journal of Clinical Immunology|November 1, 1995
Immune deficiency following thermal trauma is associated with apoptotic cell deathJ A Teodorczyk-Injeyan, M Cembrzynska-Nowak, S Lalani, et al.
AIDS (London, England)|September 1, 1996
HIV infection in vitro enhances the activity of src-family protein tyrosine kinasesD J Phipps, S E Read, J P Piovesan, et al.
Clinical Chemistry|November 13, 2012
The impact of tumor heterogeneity on patient treatment decisionsCarol J Farhangfar, Funda Meric-Bernstam, John Mendelsohn, et al.
Molecular Cancer Therapeutics|October 17, 2006
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cellsRaoul Tibes, Yihua Qiu, Yiling Lu, et al.
European Journal of Immunology|December 1, 1987
Response of human B cells to different anti-immunoglobulin isotypes: absence of a correlation between early activation events and cell proliferationC M Roifman, G B Mills, D Stewart, et al.
Pageof 140

Showing results (401-410 of 1,398) with videos related to

Sort By:
Pageof 140
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)G S Hagopian, G B Mills, A R Khokhar, et al.
British Journal of Cancer|November 30, 2019
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancersMusaffe Tuna, Zhenlin Ju, Kosuke Yoshihara, et al.
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data SetsWei Zhao, Matthew Fitzgibbon, Lindsay Bergan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Dissociation of cytokine signals for proliferation and apoptosisY Shi, R Wang, A Sharma, et al.
Nature Communications|April 15, 2020
Sex-associated molecular differences for cancer immunotherapyYouqiong Ye, Ying Jing, Liang Li, et al.
Journal of Clinical Immunology|November 1, 1995
Immune deficiency following thermal trauma is associated with apoptotic cell deathJ A Teodorczyk-Injeyan, M Cembrzynska-Nowak, S Lalani, et al.
AIDS (London, England)|September 1, 1996
HIV infection in vitro enhances the activity of src-family protein tyrosine kinasesD J Phipps, S E Read, J P Piovesan, et al.
Clinical Chemistry|November 13, 2012
The impact of tumor heterogeneity on patient treatment decisionsCarol J Farhangfar, Funda Meric-Bernstam, John Mendelsohn, et al.
Molecular Cancer Therapeutics|October 17, 2006
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cellsRaoul Tibes, Yihua Qiu, Yiling Lu, et al.
European Journal of Immunology|December 1, 1987
Response of human B cells to different anti-immunoglobulin isotypes: absence of a correlation between early activation events and cell proliferationC M Roifman, G B Mills, D Stewart, et al.
Pageof 140